#BEGIN_DRUGCARD DB04048

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C4H8N2O3

# Chemical_IUPAC_Name:
(2R)-2-(carbamoylamino)propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Carbamoyl-Alanine

# HET_ID:
NCB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H8N2O3/c1-2(3(7)8)6-4(5)9/h2H,1H3,(H,7,8)(H3,5,6,9)/t2-/m1/s1

# InChI_Key:
InChIKey=LUSWEUMSEVLFEQ-UWTATZPHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4048

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
132.1179

# Molecular_Weight_Mono:
132.053492132

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QMV

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-0.35

# Predicted_Water_Solubility:
5.90e+01 g/l

# Primary_Accession_No:
DB04048

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1535935

# PubChem_Substance_ID:
46506262

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02308

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H](NC(N)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:53 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
PRDX2

# Drug_Target_1_GenBank_ID_Gene:
Z22548

# Drug_Target_1_GenBank_ID_Protein:
438069

# Drug_Target_1_GeneCard_ID:
PRDX2

# Drug_Target_1_Gene_Name:
PRDX2

# Drug_Target_1_Gene_Sequence:
>597 bp
ATGGCCTCCGGTAACGCGCGCATCGGAAAGCCAGCCCCTGACTTCAAGGCCACAGCGGTG
GTTGATGGCGCCTTCAAAGAGGTGAAGCTGTCGGACTACAAAGGGAAGTACGTGGTCCTC
TTTTTCTACCCTCTGGACTTCACTTTTGTGTGCCCCACCGAGATCATCGCGTTCACAACC
GTGAAGAGGACTTCCGCAAAGCTGGGCTGTGAAGTGCTGGGCGTCTCGGTGGACTCTCAG
TTCACCCACCTGGCTTGGATCAACACCCCCCGGAAAGAGGGAGGCTTGGGCCCCTTGAAC
ATCCCCCTGCTTGCTGACGTGACCAGACGCTTGTCTGAGGATTACGGCGTGCTGAAAAAC
GATGAGGGCATTGCTTACAGGGGCCTCTTTATCATCGATGGCAAGGGTGTCCTTCGCCAG
ATCACTGTTAATGATTTGCCTGTGGGACGCTCCGTGGATGAGGCTCTGCGGCTGGTCCAG
GCCTTCCAGTACACAGACGAGCATGGGGAAGTTTGTCCGGCTGCTTGGAAGCCTGGACGT
GACACGATTAAGCCGAACGTGGATGACAGCAAGGAATATTTCTCCAAACACAATTAG

# Drug_Target_1_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_1_General_References:
11904290	Rabilloud T, Heller M, Gasnier F, Luche S, Rey C, Aebersold R, Benahmed M, Louisot P, Lunardi J: Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem. 2002 May 31;277(22):19396-401. Epub 2002 Mar 19.
1286667	Rasmussen HH, van Damme J, Puype M, Gesser B, Celis JE, Vandekerckhove J: Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes. Electrophoresis. 1992 Dec;13(12):960-9.
8026862	Shau H, Butterfield LH, Chiu R, Kim A: Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics. 1994;40(2):129-34.
8144038	Lim YS, Cha MK, Kim HK, Kim IH: The thiol-specific antioxidant protein from human brain: gene cloning and analysis of conserved cysteine regions. Gene. 1994 Mar 25;140(2):279-84.
8313871	Golaz O, Hughes GJ, Frutiger S, Paquet N, Bairoch A, Pasquali C, Sanchez JC, Tissot JD, Appel RD, Walzer C, et al.: Plasma and red blood cell protein maps: update 1993. Electrophoresis. 1993 Nov;14(11):1223-31.
9150948	Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, Simpson RJ: A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis. 1997 Mar-Apr;18(3-4):605-13.

# Drug_Target_1_HGNC_ID:
HGNC:9353

# Drug_Target_1_HPRD_ID:
02763

# Drug_Target_1_ID:
3599

# Drug_Target_1_Locus:
19p13.2

# Drug_Target_1_Molecular_Weight:
21892

# Drug_Target_1_Name:
Peroxiredoxin-2

# Drug_Target_1_Number_of_Residues:
198

# Drug_Target_1_PDB_ID:
1QMV

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00578	AhpC-TSA

# Drug_Target_1_Protein_Sequence:
>Peroxiredoxin-2
MASGNARIGKPAPDFKATAVVDGAFKEVKLSDYKGKYVVLFFYPLDFTFVCPTEIIAFSN
RAEDFRKLGCEVLGVSVDSQFTHLAWINTPRKEGGLGPLNIPLLADVTRRLSEDYGVLKT
DEGIAYRGLFIIDGKGVLRQITVNDLPVGRSVDEALRLVQAFQYTDEHGEVCPAGWKPGS
DTIKPNVDDSKEYFSKHN

# Drug_Target_1_Reaction:
2 R'-SH + ROOH = R'-S-S-R' + H2O + ROH

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Involved in redox regulation of the cell. Reduces peroxides with reducing equivalents provided through the thioredoxin system. It is not able to receive electrons from glutaredoxin. May play an important role in eliminating peroxides generated during metabolism. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2)

# Drug_Target_1_SwissProt_ID:
P32119

# Drug_Target_1_SwissProt_Name:
PRDX2_HUMAN

# Drug_Target_1_Synonyms:
EC 1.11.1.15
NKEF-B
Natural killer cell-enhancing factor B
PRP
TSA
Thiol-specific antioxidant protein
Thioredoxin peroxidase 1
Thioredoxin-dependent peroxide reductase 1

# Drug_Target_1_Theoretical_pI:
5.75

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04048
